GXI Gerresheimer AG

XETRA · DE · Healthcare · Medical Instruments & Supplies · gerresheimer.com

28.40EUR+3.20%Mkt Cap: 1.07B $P/E: —Today

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap1.07B USD

Enterprise Value3.41B USD

Revenue (TTM)2.52B USD

Gross Profit462.23M USD

Net Income (TTM)-348.17M USD

Revenue/Share67.09 EUR

Last Price28.40 EUR

Fiscal Year EndNov 2025

MR QuarterFeb 2026

Employees13.3K

CountryDE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINDE000A0LD6E6

Valuation

P/E (Trailing)—

P/E (Forward)9.04

PEG1.23

EV/EBITDA9.70

EV/Revenue1.35

P/S0.41

P/B0.88

EPS (TTM)-9.27

EPS (Forward)3.04

52W Range

14.8358% of range38.28

52W High38.28 EUR

52W Low14.83 EUR

Profitability

Gross Margin18.32%

Oper. Margin-10.96%

EBITDA Margin13.95%

Profit Margin-13.80%

ROE-29.63%

ROA-7.13%

Growth

Revenue Growth-0.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF227.75M USD

CapEx (TTM)335.13M USD

FCF Margin-7.58%

FCF Yield-17.92%

Net Debt2.35B USD

Net Debt/EBITDA6.68

Balance Sheet

Debt/Equity2.01

Current Ratio1.07

Quick Ratio0.29

Book Value/Sh31.30 EUR

Cash/Share4.85 EUR

Dividends

Fwd Div Rate0.04 EUR

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield0.43%

Payout Ratio3.85%

Ex-Div DateJun 6, 2025

Pay Date—

Analyst Consensus

Rating3.2 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)27.38 EUR

Upside (mean)-3.6%

Target Range20.00 EUR – 46.00 EUR

20.00-3.6% to mean46.00

# Analysts12

Ownership

Shares Out.34.54M

Float32.05M

Insiders11.42%

Institutions73.55%

Technical

SMA 5027.38 (+3.7%)

SMA 20024.82 (+14.4%)

Beta0.48

S&P 52W Chg14.58%

Avg Vol (30d)145.01K

Avg Vol (10d)121.09K

Technical Indicators

RSI (14)50.5

MACD0.0007

MACD Signal-0.0739

MACD Hist.+0.0746

BB Upper29.75 EUR

BB Middle27.63 EUR

BB Lower25.52 EUR

BB Width15.31%

ATR (14)1.181 EUR

Vol Ratio (20d)0.57x